151 – 160 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Regional Differences in Effects of APOE epsilon 4 on Cognitive Impairment in Non-Demented Subjects
(
- Contribution to journal › Article
-
Mark
Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment.
(
- Contribution to journal › Article
-
Mark
Prediction of Alzheimer's Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide: A Retrospective Analysis of 134 Patients With Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.
(
- Contribution to journal › Article
-
Mark
No Association of LOXL1 Gene Polymorphisms with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.
(
- Contribution to journal › Article
-
Mark
Differences in Survival between Patients with Dementia with Lewy Bodies and Patients with Alzheimer's Disease - Measured from a Fixed Cognitive Level.
(
- Contribution to journal › Article
-
Mark
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment.
(
- Contribution to journal › Article